[1] |
LIU Na, LI Pin, WANG Qixia, LI Mingming, HUANG Shuhong, DANG Ningning.
Synergistic effect of EphB6 overexpression and BRAFi treatment in inhibiting the metastatic progression of melanoma
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(8): 524-529.
|
[2] |
CHEN Jianyou, ZHANG Gaolei, LIU Xiaoyan.
Update of diagnosis and treatment of congenital pigmented nevus
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(5): 338-342.
|
[3] |
ZHANG Qianqian, QI Zhaoliang, YANG Hui, WANG Xiaoyan.
Reactive cutaneous capillary endothelial proliferation caused by PD-1 inhibitor camrelizumab: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(4): 232-235.
|
[4] |
SONG Hongbin, LIU Yuehua.
Progress in the treatment of skin diseases with tyrosine kinase inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(4): 260-264.
|
[5] |
ZHU Yajing, LIU Yuyuan, ZHANG Jinli, HUANG Hong.
Nodular malignant melanoma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(3): 172-174.
|
[6] |
HE Chunxia, SI Xiaoyan, QU Tao, ZHANG Li.
Psoriasis induced by immune checkpoint inhibitor pembrolizumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(1): 3-7.
|
[7] |
YUE Zhanghui, WANG Yan, FANG Fang, SUN Jianfang.
Update of RNA-related epigenetics of melanoma
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(8): 509-512.
|
[8] |
WANG Jing, MA Guozhang, LIU Xiguang.
Subungual melanoma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(7): 417-419.
|
[9] |
TAN Zimin, YANG Chenglian, ZHONG Guishu, ZENG Fancai.
Effect of hypoxia on the expression of Nodal and the impact of relative migration protein in malignant melanoma A375 cells
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(6): 339-342.
|
[10] |
YANG Jing, CAI Mei, ZHOU Xiaohong, XIONG Zhen.
Amelanotic melanoma on the forehead: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(5): 289-292.
|
[11] |
HAN Yue, YAO Xu.
The role of programmed cell death-1 in allergic diseases
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(5): 307-312.
|
[12] |
WANG Shuangshuang, ZHANG Yifen, GAO Lili, LI Hui, ZHAO Susu.
Clinic features and P16 expression level in the patients with Spitz nevus or malignant melanoma
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(10): 588-590.
|
[13] |
LI Ming, ZHOU Boyang, LI Linfeng.
Cutaneous adverse reactions of PD-1/PD-L1 inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(8): 509-512.
|
[14] |
CAI Haibin, XU Shunming, CAO Lei, XU Yang.
Penile malignant melanoma: a case report and literatures review
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(6): 352-355.
|
[15] |
ZHANG Qianqian, MENG Xianguang, HUANG Shuhong, DANG Ningning.
Lyn inhibitor Bafetinib inhibits the proliferation and promotes the apoptosis of human malignant melanoma cell UACC62
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(12): 705-707.
|